Invention Grant
- Patent Title: Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand
-
Application No.: US14852623Application Date: 2015-09-13
-
Publication No.: US10088485B2Publication Date: 2018-10-02
- Inventor: Christine Victoria Ichim
- Applicant: Regen BioPharma, Inc
- Applicant Address: US CA La Mesa
- Assignee: Regen Biopharma
- Current Assignee: Regen Biopharma
- Current Assignee Address: US CA La Mesa
- Agency: Baumgartner Patent Law
- Agent Marc Baumgartner
- Main IPC: A61K38/00
- IPC: A61K38/00 ; G01N33/68 ; A61K31/00 ; A61K31/7088 ; G01N33/574
Abstract:
The current invention discloses compositions of matter, protocols and methods of screening test compounds to identifying agonists and antagonists of the orphan nuclear receptor NR2F6 by measuring the ability of a test compound to occupy the active site of NR2F6, in the presence of a reference compound.
Public/Granted literature
- US20160025746A1 METHODS OF SCREENING COMPOUNDS THAT CAN MODULATE NR2F6 BY DISPLACEMENT OF A REFERENCE LIGAND Public/Granted day:2016-01-28
Information query
IPC分类:
